Cargando…
Germline genetic host factors as predictive biomarkers in immuno-oncology
In immuno-oncology (IO), the baseline host factors attract significant clinical interest as promising predictive biomarker candidates. Growing evidence from experimental or population-based studies suggests that the host genetic factors contribute to the immunological status of a patient as it plays...
Autores principales: | Chat, Vylyny, Ferguson, Robert, Kirchhoff, Tomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216465/ https://www.ncbi.nlm.nih.gov/pubmed/35756849 http://dx.doi.org/10.1016/j.iotech.2019.08.001 |
Ejemplares similares
-
A genome-wide association study of germline variation and melanoma prognosis
por: Chat, Vylyny, et al.
Publicado: (2023) -
Ultra Low-Coverage Whole-Genome Sequencing as an Alternative to Genotyping Arrays in Genome-Wide Association Studies
por: Chat, Vylyny, et al.
Publicado: (2022) -
Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM)
por: Ferguson, Robert, et al.
Publicado: (2019) -
The evolving landscape of predictive biomarkers in immuno‐oncology with a focus on spatial technologies
por: Sadeghi Rad, Habib, et al.
Publicado: (2020) -
Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017)